|
In This Issue |
|
Feature
Articles |
|
The
worsening world economy and sarcoma advocacy
Editorial by Bruce
Shriver, PhD |
|
CTOS Op Ed:
Extra-abdominal primary fibromatosis: strategy according
to molecular findings?
Sylvie Bonvalot, MD, PhD contends that
prospective studies are needed to
understand the molecular mechanisms behind desmoid tumorigenesis and
progression and to confirm whether some mutations are at particular risk for
recurrence or progression.
|
|
Telomere
maintenance mechanisms in liposarcomas
Dominique Broccoli, Ph.D.
describes her research evaluating the
telomere maintenance mechanism associated
differences in liposarcomas. |
|
Open access: a basic right underlying
participatory medicine
Gilles Frydman argues that the necessity of Open Access
to promote participatory medicine is clear. |
|
Issues of assessment and adjustment following
a cancer diagnosis
Marianne Griffin
RN, BA and Kate Thompson BA.
BSW suggest that
Comprehensive psychosocial assessment
during the early stages of treatment is critical and should be considered as
a priority in conjunction with the medical and physical aspects of an
individual’s treatment plan. |
|
Dr. Raphael Pollock Joins Medical
Advisory and Editorial Advisory Boards
We are pleased to
announce that Dr. Raphael Pollock, an internationally distinguished
physician has joined our Medical Advisory and Editorial Board. |
|
Honoring Rose Burt's Memory
A $50,000 liposarcoma research grant is
awarded in memory of Rose Burt. |
|
A Partial Index to Articles that have
Appeared in ESUN
An update
to the partial index to ESUN articles. |
|
Regular
Columns |
|
Clinical
Trial News
Abstracts of clinical trials that sarcoma
patients may be eligible to participate are given
in two categories:
 |
Currently Accepting Eligible Patients (not previously published in
ESUN) |
|
|
Currently
Accepting Eligible Patients (previously published in ESUN: amended
protocol) |
|
|
Not
Yet Recruiting Patients (not previously published in ESUN) |
|
|
Odds & Ends
Pointers to resources and abstracts of
interesting articles. In this issue:
|
|
A Review of Patient Decision Aids to Support Patient
Participation |
|
|
Molecular Origins of Cancer: Chromosomal
Abnormalities in Cancer |
|
|
Fandango
|
|
|
Understanding Your Complete Blood Count
|
|
|
The Polish Sarcoma Patients Association 2008 Onco-Run
|
|
|
Childhood Cancer: Where's The Money?
|
|
|
Effect of Childhood Cancer Treatment on Male
Fertility |
|
|
Delays in Referral to Specialist for Treatment of
Soft Tissue Sarcomas
|
|
|
Zeltia Says Yondelis Sales to Exceed 1 Billion Euros
|
|
|
BSD Medical Corp. Announces ESMO Recommends
Hyperthermia as 'Standard Therapy' for Soft Tissue
Sarcoma |
|
|
Pazopanib Shows Encouraging Activity In Several
Tumor Types, Including Soft Tissue Sarcoma
|
|
|
ArQule Confirms Tumor Response In MiT Trial With ARQ
197 In Clear Cell Sarcoma And Expands Trial
|
|
|
At Press Time
|
|
|
Research Corner
Abstracts of recent sarcoma-related research articles. In this issue:
|
|
Dasatinib Inhibits Migration
and Invasion in Diverse Human Sarcoma Cell Lines and Induces
Apoptosis in Bone Sarcoma Cells Dependent on Src Kinase for Survival
|
|
|
CD8+ T-Cell
Responses against Hemoglobin-β Prevent Solid Tumor Growth
|
|
|
Ritonavir induces
endoplasmic reticulum stress and sensitizes sarcoma cells toward
bortezomib-induced apoptosis |
|
|
Microsatellites as
EWS/FLI response elements in Ewing's sarcoma
|
|
|
COX-2 Expression
Correlates With Survival in Patients With Osteosarcoma Lung
Metastases |
|
|
Results of the
EICESS-92 Study: two randomized trials of Ewing's sarcoma
treatment--cyclophosphamide compared with ifosfamide in
standard-risk patients and assessment of benefit of etoposide added
to standard treatment in high-risk patients.
|
|
|
Factors associated
with actual long-term survival following soft tissue sarcoma
pulmonary metastasectomy |
|
|
High level of
mitogen-activated protein kinase phosphatase-1 expression is
associated with cisplatin resistance in osteosarcoma
|
|
|
A Pivotal Role for
Heat Shock Protein 90 in Ewing Sarcoma Resistance to
Anti-Insulin-like Growth Factor 1 Receptor Treatment: In vitro and
In vivo Study |
|
|
Screening for
Neurocognitive Impairment in Pediatric Cancer Long-Term Survivors
|
|
|
PDGFR-A is a
Therapeutic Target in Alveolar Rhabdomyosarcoma
|
|
|
Stories of Courage and Hope
Abstracts
of
inspiring stories we have recently encountered
about
sarcoma patients, survivors,
caregivers and those who have lost a loved one to sarcoma.
In this issue:
|
|
Anna's effort
"Taught us how to live"
|
|
|
Kirk Offel -
Pursuing A Promise |
|
|
World champion
shares cancer, sports victories |
|
|
Two-time Cancer
Survivor Tackles Ironman |
|
|
There's Just No
Getting Petrick Down |
|
|
Gold Ribbon Day
Glitters Hope For Childhood Cancer
|
|
|
Teen Sarcoma
Victim Never Lost Her Smile |
|
|
Family and Friends
Come Together to Help Sarcoma Patient
|
|
|
Sarcoma
Survivor Credits Power of Prayer |
|
|
Our Initiatives
Brief descriptions of some of the Liddy Shriver Sarcoma
Initiative projects are presented. In
this issue:
|
|
2009 Team Sarcoma Event Planning Underway
|
|
|
The Faces of Sarcoma
Project
|
|
|
The "Sarcoma Knows No Borders" Bracelet
|
|
|
Team Sarcoma T-Shirts and other Odds & Ends
|
|
|
Tri-Folds, Sarcoma Facts Sheet, and Poster Available
|
|
|
Music CD,
The
Circle, Benefits Sarcoma Research
|
|
|
Clinical trial abstracts now exceed
370
|
|
|
Guest Book
|
|
|
General
Information |
|
Disclaimer |
|
Medical Editorial Board and Editorial Staff |
|
Registering to
Receive Notifications About ESUN
Send
us a note containing your e-mail address if you would like
to receive a note when the next issue of
ESUN
is
published. |
|
Topics and Feedback
Please
send
us your recommendations for topics that you would like to
see covered in
ESUN as well as any other comments or
feedback that can be useful to us. We also welcome contributions
of essays and articles that are relevant to
ESUN and its intended audience |
